Clinical trial

Anakinra as a Rescue Treatment for Allergic Inflammation

NCT04035109

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Anakinra Normalized identity: anakinraView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Preservative-free 0.9% sodium chloride (Placebo) Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention House dust mite allergen Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Cat hair allergen Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Anakinra as a Rescue Treatment for Allergic Inflammation

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2019-12-16

PhasePHASE1 / PHASE2

Conditions

Asthma, Allergicunresolved

Interventions

AnakinraDRUG · verified · RxNorm: anakinra

Preservative-free 0.9% sodium chloride (Placebo)DRUG

House dust mite allergenBIOLOGICAL

Cat hair allergenBIOLOGICAL

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04035109 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.